ICD-10 category · Chapter II · D37-D48

D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue

9 codes under D47 in the South African Master Industry Table 2021, 8 valid for clinical use; 2 marked as a Prescribed Minimum Benefit.

Valid: the code is at its most specific level and may go on an account. Heading only: code to a more specific entry beneath it. PMB and CDL: a Prescribed Minimum Benefit or Chronic Disease List condition per the Council for Medical Schemes. † dagger and * asterisk codes are used as a pair. How to read the table
Code	Description	Use	Benefits
D47	Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	Heading only	—
D47.0	Histiocytic and mast cell tumours of uncertain and unknown behaviour	Valid · may be primary	PMB 937S Tumour of internal organ (excludes skin): unknown whether benign or malignant · BiopsyPMB 954J Cancer of skin, excluding malignant melanoma - treatable · If histologically confirmed, Medical and surgical management, which includes radiation therapy
D47.1	Chronic myeloproliferative disease	Valid · may be primary	—
D47.2	Monoclonal gammopathy of undetermined significance (MGUS)	Valid · may be primary	—
D47.3	Essential (haemorrhagic) thrombocythaemia	Valid · may be primary	—
D47.4	Osteomyelofibrosis	Valid · may be primary	—
D47.5	Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	Valid · may be primary	PMB 910S Multiple myeloma and chronic leukaemias · Medical management which includes chemotherapy and radiation therapy
D47.7	Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	Valid · may be primary	—
D47.9	Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	Valid · may be primary	—

Prescribed Minimum Benefits in D47. A medical scheme must fund the diagnosis, treatment and care of a PMB condition in full, within its rules on designated providers and treatment protocols. The PMB code and treatment component beside each code come from the Council for Medical Schemes’ PMB Coded List; the scheme decides whether a given claim qualifies.

Source and terms

Reproduced from the national table, unaltered.

The Department publishes the table for the industry to load. The ICD-10 Master Industry Table page

Codes and descriptions: ICD-10 Master Industry Table (MIT) 2021, published 16 March 2021 by the National Department of Health, Republic of South Africa. ® National Department of Health: all rights reserved. Reproduced for reference without alteration.

ICD-10 is the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, © World Health Organization. The WHO ICD-10 descriptions appear as published in the MIT.

Prescribed Minimum Benefit (PMB) and Chronic Disease List (CDL) markers: Council for Medical Schemes, PMB Coded List, as read by GreenNotes. Benefit decisions rest with each medical scheme.

Source file: ICD-10_MIT_2021_Excel_16-March_2021.xlsx. Found an error in a code or description? Write to help@greennotes.co.za.

This lookup is a reference to the published code table, not coding advice. Code assignment is the treating practitioner’s responsibility, following the South African ICD-10 Coding Standards and Guidelines and the WHO ICD-10 volumes. GreenNotes does not warrant that the table is complete or current.

This is the South African table. Most ICD-10 results online are the United States’ ICD-10-CM, a different code set that South African medical schemes do not accept. Regulation 5 of the General Regulations under the Medical Schemes Act requires the diagnostic code on every account, and the Master Industry Table is the list it is coded from.

In GreenNotes

Code the consultation once. The invoice and the claim pick it up.

GreenNotes looks codes up from this same table while you write the consultation. The codes you record there, including any the clinical AI included for your review, carry into the invoice and the medical-aid claim.

Start a 14-day Clinical trial See notes become claims